-
Immigrants make up a significant proportion of all the country's doctors. New policies are making it harder and less appealing for foreign-born physicians to come to the U.S.
-
Weight-loss drugs like Wegovy and Zepbound often cause nausea and other side effects. Brain scientists are looking for ways to solve this problem.
-
Some senior living communities are caring for people with dementia alongside other residents, not segregated behind locked doors.
-
Research on brain disorders may slow as young neuroscientists struggle to find jobs and research grants.
-
Health Secretary Robert F. Kennedy Jr.'s Centers for Disease Control and Prevention has launched an unprecedented review of routine shots given to kids, alarming public health experts.
-
Medicare beneficiaries will soon be able to get obesity and Type 2 diabetes drugs for a $50 copay. But there are some limitations.
-
Telehealth for Medicare started during the pandemic and became popular quickly. But the shutdown put an abrupt halt to payments for the service.
-
The White House plans to bar hospitals that treat transgender children and youth from getting any Medicare and Medicaid payments. The move would affect trans youth who have private insurance, too.
-
A new poll shows trust in federal health policies is plummeting, and what — or who — people believe increasingly depends on their politics.
-
After warning Congress for months about premium spikes, the leader of the country's insurance commissioners — a Republican from North Dakota — says he's hopeful there could be a last minute fix.
-
Access to the COVID-19 vaccines remains difficult because of an unusual and unexplained delay by the Centers for Disease Control and Prevention in accepting recommendations from its advisers.
-
Mississippi recently declared a public health emergency because its infant mortality rate has surged. And with Medicaid cuts coming, experts fear the crisis may worsen in other states.